111 related articles for article (PubMed ID: 8968395)
1. Inhibition of plasminogen activator inhibitor-1 activity by two diketopiperazines, XR330 and XR334 produced by Streptomyces sp.
Bryans J; Charlton P; Chicarelli-Robinson I; Collins M; Faint R; Latham C; Shaw I; Trew S
J Antibiot (Tokyo); 1996 Oct; 49(10):1014-21. PubMed ID: 8968395
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity.
Charlton PA; Faint RW; Bent F; Bryans J; Chicarelli-Robinson I; Mackie I; Machin S; Bevan P
Thromb Haemost; 1996 May; 75(5):808-15. PubMed ID: 8725728
[TBL] [Abstract][Full Text] [Related]
3. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
4. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
5. A new diketopiperazine derivative from a deep sea-derived Streptomyces sp. SCSIO 04496.
Luo M; Tang G; Ju J; Lu L; Huang H
Nat Prod Res; 2016; 30(2):138-43. PubMed ID: 26197797
[TBL] [Abstract][Full Text] [Related]
6. Fibrin-specific fibrinolysis.
Collen D; Lijnen HR
Ann N Y Acad Sci; 1992 Dec; 667():259-71. PubMed ID: 1285022
[No Abstract] [Full Text] [Related]
7. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
8. High glucose reduces generation of plasmin activity by mesangial cells.
Fisher EJ; McLennan SV; Yue DK; Turtle JR
Microvasc Res; 1997 Mar; 53(2):173-8. PubMed ID: 9143550
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of plasminogen activator inhibitor-1 by 11-keto-9(E),12(E)-octadecadienoic acid, a novel fatty acid produced by Trichoderma sp.
Chikanishi T; Shinohara C; Kikuchi T; Endo A; Hasumi K
J Antibiot (Tokyo); 1999 Sep; 52(9):797-802. PubMed ID: 10726927
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1.
Folkes A; Roe MB; Sohal S; Golec J; Faint R; Brooks T; Charlton P
Bioorg Med Chem Lett; 2001 Oct; 11(19):2589-92. PubMed ID: 11551756
[TBL] [Abstract][Full Text] [Related]
11. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.
Sandra D; Radha M; Harishkumar M; Yuichi N; Sayuri O; Masugi M
Phytomedicine; 2010 Jan; 17(1):42-6. PubMed ID: 19640694
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.
Endo A; Nagai N; Urano T; Ihara H; Takada Y; Hashimoto K; Takada A
Neurosci Lett; 1998 Apr; 246(1):37-40. PubMed ID: 9622202
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin and vascular fibrinolytic balance.
Vaughan DE
Am J Hypertens; 2002 Jan; 15(1 Pt 2):3S-8S. PubMed ID: 11824873
[TBL] [Abstract][Full Text] [Related]
15. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
16. Functional evaluation of plasmin formation in primary breast cancer.
Chappuis PO; Dieterich B; Sciretta V; Lohse C; Bonnefoi H; Remadi S; Sappino AP
J Clin Oncol; 2001 May; 19(10):2731-8. PubMed ID: 11352966
[TBL] [Abstract][Full Text] [Related]
17. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
[TBL] [Abstract][Full Text] [Related]
18. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
Moniwa N
Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
[TBL] [Abstract][Full Text] [Related]
19. Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits.
Friederich PW; Levi M; Biemond BJ; Charlton P; Templeton D; van Zonneveld AJ; Bevan P; Pannekoek H; ten Cate JW
Circulation; 1997 Aug; 96(3):916-21. PubMed ID: 9264501
[TBL] [Abstract][Full Text] [Related]
20. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
Meissauer A; Kramer MD; Schirrmacher V; Brunner G
Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]